A comprehensive review of the protein subunit vaccines against COVID-19
Two years after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
Development in the concept of bacterial polysaccharide repeating unit-based antibacterial conjugate vaccines
R Rohokale, Z Guo - ACS infectious diseases, 2023 - ACS Publications
The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx.
The complex glycans in the glycocalyx are involved in various biological events, such as …
The complex glycans in the glycocalyx are involved in various biological events, such as …
The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development
M Kozak, J Hu - Vaccines, 2023 - mdpi.com
Vaccines have proven to be the most cost-efficient and reasonable way to fight and
exterminate virulent pathogens. Vaccines can be designed using a variety of platforms …
exterminate virulent pathogens. Vaccines can be designed using a variety of platforms …
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and vaccine effectiveness
SRV Tulimilli, S Dallavalasa, CG Basavaraju… - Vaccines, 2022 - mdpi.com
The incidence and death toll due to SARS-CoV-2 infection varied time-to-time; and
depended on several factors, including severity (viral load), immune status, age, gender …
depended on several factors, including severity (viral load), immune status, age, gender …
An immunological review of SARS-CoV-2 infection and vaccine serology: innate and adaptive responses to mRNA, adenovirus, inactivated and protein subunit …
The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which is defined by its positive …
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which is defined by its positive …
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
After two years since the declaration of COVID-19 as a pandemic by the World Health
Organization (WHO), more than six million deaths have occurred due to SARS-CoV-2 …
Organization (WHO), more than six million deaths have occurred due to SARS-CoV-2 …
Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future
Z Zeng, X Geng, X Wen, Y Chen, Y Zhu… - Frontiers in …, 2023 - frontiersin.org
Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
its resultant pneumonia in December 2019, the cumulative number of infected people …
its resultant pneumonia in December 2019, the cumulative number of infected people …
COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations
MA Raheem, MA Rahim, I Gul, M Reyad-ul-Ferdous… - Life Sciences, 2024 - Elsevier
SARS-CoV-2 is a highly contagious pathogen that predominantly caused the COVID-19
pandemic. The persistent effects of COVID-19 are defined as an inflammatory or host …
pandemic. The persistent effects of COVID-19 are defined as an inflammatory or host …
Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study
SF Mousavi, M Ebrahimi, SAA Moghaddam, N Moafi… - Vacunas, 2023 - Elsevier
Background Nowadays, the world is facing a coronavirus disease (COVID-19) pandemic,
elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At the time …
elicited by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At the time …
COVID-19 vaccines: where did we stand at the end of 2023?
K Lundstrom - Viruses, 2024 - mdpi.com
Vaccine development against SARS-CoV-2 has been highly successful in slowing down the
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …
COVID-19 pandemic. A wide spectrum of approaches including vaccines based on whole …